Pfizer Inc (PFE) Down 2.15%, Crosses 50, 100 and 200 Day Moving Averages; in a Downtrend Over Past 14 Days

Pfizer Inc Daily Price Recap

Pfizer Inc entered today at $36.4, down 2.15% ($0.8) from the day prior. The price move occurred on stronger volume; specifically, yesterday’s volume was up 23.7% from the day prior, and up 37.06% from the same day the week before. The daily price chart of Pfizer Inc below illustrates.


Pfizer Inc Technical Analysis

Moving average crossovers are always interesting, so let’s start there: Pfizer Inc crossed below its 50, 100 and 200 day moving averages yesterday. Trend traders will want to observe that the strongest trend appears on the 14 day horizon; over that time period, price has been moving down. For another vantage point, consider that Pfizer Inc’s price has gone down 8 of the previous 14 trading days.

Overheard Around the Web

Over on StockTwits, here’s an example of what they’re saying about PFE:

    $PFE Need some advice from professional option players, I just started playing options last month and still learning. My gut feeling is Pfizer will have a vaccine and get an fda approval. I want to buy 1000 Pfizer $50 call options. Pfizer may have the positive clinical data released in late October or November and FDA approval in November or December. My question is which expiration I should buy in for decent profit and safe at the Same time ? 11/20/20, 12/18,20 or 01/15/21, Considering decay in options premium , giving ample time for positive data and fda approval ? Please advice